Article

SARS-CoV-2 Seroprevalence, Cumulative Infections, and Immunity to Symptomatic Infection – A Multistage National Household Survey and Modeling Study, Dominican Republic, June–October 2021

2022-07-14

Abstract excerpt

Background: Population-level SARS-CoV-2 immunological protection is poorly understood but can guide vaccination and non-pharmaceutical intervention priorities. Our objective was to characterize cumulative infections and immunological protection in the Dominican Republic Methods: Household members ≥5 years were enrolled in a three-stage national household cluster serosurvey in the Dominican Republic. We meas...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: feee0706-455e-534b-a3c7-324b52053757
DOI: 10.2139/ssrn.4162715

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Seroprevalence, Cumulative Infections, and Immunity to Symptomatic Infection – A Multistage National Household Survey and Modeling Study, Dominican Republic, June–October 2021DOI 10.2139/ssrn.4162715Read

Integrated SARS-CoV-2 serological and virological screening across an acute fever surveillance platform to monitor temporal changes in anti-spike antibody levels and risk of infection during sequential waves of variant transmission — Dominican Republic, March 2021 to August 2022Semantic proximity Read

An immune correlate of SARS-CoV-2 infection and severity of reinfectionsSemantic proximity Read

Household Transmission of SARS-CoV-2: Insights from a Population-based Serological SurveySemantic proximity Read

Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022Semantic proximity Read

U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022Semantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysisSemantic proximity Read

Serological surveys to estimate cumulative incidence of SARS-CoV-2 infection in adults (Sero-MAss study), Massachusetts, July-August 2020: a mail-based cross-sectional studySemantic proximity Read

Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022Semantic proximity Read

1st, 2nd, and 3rd+ SARS-CoV-2 infections: associations of prior infections with protection and severitySemantic proximity Read

Estimated SARS-CoV-2 Antibody Seroprevalence and Infection to Case Ratio Trends in 50 States and District of Columbia, United States—October 25, 2020, to February 26, 2022Semantic proximity Read

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsSemantic proximity Read